Announcement of an Exempt Purchase

The implants provided by Boston Scientific are radiopharmaceutical microspheres which are used to treat patients with liver cancer using Yttirum-90. These unique microspheres emit radiation destroying cancer cells in the tumor, while sparing healthy liver tissue.

This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Boston Scientific implants have to do with direct patient care. Without access to their Radiopharmaceutical microsphere the hospital would not be able to offer certain cancer treatment, which in turn would drive patients elsewhere and a loss in revenue to the hospital.